Rapid Sequence Intubation clinical trials at UC Irvine
1 in progress, 0 open to eligible people
Sorry, not yet accepting patients
To compare the outcomes of the use of propofol, etomidate, and ketamine as induction agents for adult trauma patients undergoing intubation within 24 hours of admission. The primary goal is to determine the ideal agent that should be used in this patient population for intubations.
Los Angeles, California
Our lead scientists for Rapid Sequence Intubation research studies include Jeffry T Nahmias, MD.